Cart
sales@molnova.com
Oosporein
CAS No. 475-54-7
Oosporein( —— )
Catalog No. M34787 CAS No. 475-54-7
Oosporein is a mycotoxin produced by Trichoderma reesei with antimicrobial, antiviral and insecticidal activities, inhibits P.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 226 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameOosporein
-
NoteResearch use only, not for human use.
-
Brief DescriptionOosporein is a mycotoxin produced by Trichoderma reesei with antimicrobial, antiviral and insecticidal activities, inhibits P.
-
DescriptionOosporein is a red crystalline metabolite produced by a toxin-producing strain of Chaetomium trilaterale. Chaetomium trilaterale is isolated from moldy Peanuts. Oosporein inhibits plant growth and produces phytotoxic effects.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetDNA/RNA Synthesis
-
RecptorDNA/RNA Synthesis | Antiviral | Antibacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number475-54-7
-
Formula Weight306.22
-
Molecular FormulaC14H10O8
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 50 mg/mL (163.28 mM)
-
SMILESO=C1C(O)=C(C(=O)C(O)=C1C=2C(=O)C(O)=C(C(=O)C2O)C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Cole RJ, et al. Toxic effects of oosporein from Chaetomium trilaterale. J Agric Food Chem. 1974;22(3):517-520.?
molnova catalog
related products
-
Asimadoline
Asimadoline is a proprietary small molecule therapeutic, originally developed to treat peripheral pain such as arthritis.
-
Sodium Camptothecin
Sodium Camptothecin is a plant alkaloid, with antitumor activity. Sodium Camptothecin is a reversible inhibitor of RNA synthesis.
-
CX-3543
CX-3543 (Quarfloxin, Itarnafloxin) is a small molecule nucleolus-targeting agent that selectively disrupts nucleolin/rDNA G-quadruplex complexes in the nucleolus.
